June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Generative-adversarial-learning-based biomarker activation map for improving the interpretability of deep-learning-aided diabetic retinopathy screening
Author Affiliations & Notes
  • Pengxiao Zang
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States
    Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, United States
  • Tristan Hormel
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States
  • Jie Wang
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States
    Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, United States
  • Steven T. Bailey
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States
  • Christina J Flaxel
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States
  • David Huang
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States
  • Thomas S Hwang
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States
  • Yali Jia
    Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States
    Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, United States
  • Footnotes
    Commercial Relationships   Pengxiao Zang None; Tristan Hormel None; Jie Wang Optovue, Inc, Code P (Patent); Steven Bailey None; Christina Flaxel None; David Huang Optovue, Inc, Code F (Financial Support), Optovue, Inc, Code P (Patent), Optovue, Inc, Code R (Recipient); Thomas Hwang None; Yali Jia Optovue, Inc, Code F (Financial Support), Optovue, Inc, Code P (Patent), Optos, Inc, Code P (Patent)
  • Footnotes
    Support  National Institutes of Health (R01 EY027833, R01 EY024544, P30 EY010572); Unrestricted Departmental Funding Grant, William & Mary Greve Special Scholar Award from Research to Prevent Blindness (New York, NY)
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 211 – F0058. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Pengxiao Zang, Tristan Hormel, Jie Wang, Steven T. Bailey, Christina J Flaxel, David Huang, Thomas S Hwang, Yali Jia; Generative-adversarial-learning-based biomarker activation map for improving the interpretability of deep-learning-aided diabetic retinopathy screening. Invest. Ophthalmol. Vis. Sci. 2022;63(7):211 – F0058.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Deep learning (DL) can assist the diagnosis of diabetic retinopathy (DR) based on optical coherence tomography angiography. However, it is unclear how deep learning classification models arrive at their results, limiting discovery of DR biomarkers. To improve interpretability, a novel biomarker activation map (BAM) generation framework based on generative adversarial learning (GAL) is proposed.

Methods : 50 healthy participants and 305 patients with diabetes were recruited in this study. Masked trained retina specialists graded each eye based on 7-field fundus photography using early treatment of diabetic retinopathy study (ETDRS) criteria as either non-referable (nrDR; ETDRS score < 35) or referable (rDR; ETDRS score ≥ 35 or macular edema). Macular 3×3-mm scans for one or both eyes of each participant were acquired using a commercial 70-kHz spectral-domain OCT system. 456 superficial vascular complex (SVC) en face OCTA images were collected. The data set was divided into training (60%), validation (20%), and testing (20%) sets and used to train a referable/non-referable DR classifier that used the en face SVC angiograms as input. Two U-shaped networks were also trained as generators. The main generator was trained to produce an angiogram that the classifier would classify as nrDR from an input angiogram, while the assistant generator produces angiograms that would be classified as rDR (Fig. 1). The BAM was finally constructed as the absolute difference image between the input angiogram and output of the main generator.

Results : The diagnosis of rDR achieved an overall accuracy of 92%. Compared to the traditional class activation maps (CAMs) (Fig. 2B), the generated BAMs explicitly highlighted most of the pathological nonperfusion area, which represents the most important DR biomarker visible in the input angiogram (Fig. 2E). Unlike traditional CAMs, the BAMs ignored non-pathological features like the foveal avascular zone while emphasizing real pathological features that contribute the diagnostic decision making.

Conclusions : The generated BAMs using GAL method could provide sufficient interpretability to help clinicians utilize DL-aided referable DR screening, and help to quickly discern the DR-related pathologies. This innovation may also facilitate the new biomarker discovery on OCTA used for diagnosis of retinal vascular diseases.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×